RIA
ANIK icon

Regal Investment Advisors’s Anika Therapeutics ANIK Stock Holding History

Regal Investment Advisors’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-100
Closed -$3K – 292
2015
Q3 		$3K Buy
+100
New +$3.49K ﹤0.01% 869
2014
Q4 		– Sell
-578
Closed -$21K – 915
2014
Q3 		$21K Sell
578
-93
-14% -$4.02K 0.01% 544
2014
Q2 		$31K Buy
671
+346
+106% +$15.4K 0.01% 463
2014
Q1 		$13K Buy
325
+40
+14% +$1.49K 0.01% 590
2013
Q4 		$11K Buy
+285
New +$8.79K 0.01% 565

Other funds holding ANIK

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.57B AUM 19.49% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return

Regal Investment Advisors's ANIK Position: Q4 2015 in Review

Regal Investment Advisors sold out of Anika Therapeutics (ANIK) in Q4 2015, closing a stake of 100 shares — an estimated $3K sold.

Regal Investment Advisors first reported a position in ANIK in Q4 2013 and held it in 5 quarters. The position peaked at $31K in Q2 2014. 152 funds tracked by Wall St. Rank hold ANIK as of Q4 2015.

  • Regal Investment Advisors reported no remaining Anika Therapeutics position as of Q4 2015 after selling out during the quarter.
  • Regal Investment Advisors sold 100 Anika Therapeutics shares in Q4 2015, an estimated $3K.
  • Regal Investment Advisors first reported a position in Anika Therapeutics in Q4 2013 and held it in 5 quarters.
  • Regal Investment Advisors's Anika Therapeutics position peaked at $31K in Q2 2014.
  • 152 funds tracked by Wall St. Rank held Anika Therapeutics as of Q4 2015.

Based on Regal Investment Advisors's 13F filing for Q4 2015, filed 8 Feb 2016.